TBPH
Theravance Biopharma Inc
Price:  
9.44 
USD
Volume:  
243,048.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH Fair Value

-403.65 %
Upside

As of 2024-03-01, the Fair Value of Theravance Biopharma Inc (TBPH) is -28.66 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.44 USD, the upside of Theravance Biopharma Inc is -403.65%.

Note: valuation result may not be accurate due to the company's negative EPS.

9.44 USD
Stock Price
-28.66 USD
Fair Price
FAIR VALUE CALCULATION

TBPH Fair Value

Peter Lynch's formula is:

TBPH Fair Value
= Earnings Growth Rate x TTM EPS
TBPH Fair Value
= 25.00 x -1.15
TBPH Fair Value
= -28.66

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 5Y Avg
Net income -215.50 -236.50 -278.00 -199.40 872.10 -11.46
YoY growth 24.49% -9.74% -17.55% 28.27% 537.36% 112.57%

TBPH Fair Value - Key Data

Market Cap (mil) 470.11
P/E
Forward P/E
EPS -1.15
Avg earnings growth rate 112.57%
TTM earnings -57.10